Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.
The use of growth hormone (GH) as an anabolic agent is limited by its tendency to cause hyperglycemia and by its inability to reverse nitrogen wasting in some catabolic conditions. In a previous study comparing the anabolic actions of GH and IGF-I (insulin-like growth factor I), we observed that int...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1993
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC287936/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7679407/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116212 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|